Vir Biotechnology to Provide Pipeline Update at 38th Annual J.P. Morgan Healthcare Conference


You May Also Like

ContraFect Announces Second Quarter 2018 Financial Results

YONKERS, N.Y., Aug. 09, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...

Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress

Updated Clinical Data from Original Part 1 of IMerge in Myelodysplastic Syndromes (MDS) PresentedMENLO ...